|
|
Article: Biospace med Expands U.S. Market Penetration with 'EOS', which Cuts Radiation up to 90% vs. Conventional X-Rays.
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Biospace med announced that it continues to penetrate the U.S. market with its FDA-cleared 'EOS' x-ray imager-the world's first ultra-low-dose x-ray technology-recently adding new customers in the Midwest and Southeast regions of the United States. In addition, Professor Georges Charpak, inventor of the EOS technology, has received the 'Centenary Medal' from the French Radiological Society (SFR), the esteemed organization's highest honor. EOS can capture head-to-toe images of patients in a standing, weight-bearing position with a dramatic reduction in radiation dose-up to 10 times less than a conventional x-ray and up to 1000 times less than a CT (Computed Tomography) ...
Related newspaper, magazine, and journal articles:
|
|
Article: biospace med seeks clearance for low-dose ...
Diagnostics & Imaging Week;
July 19, 2007 ;
700+ words
...biospace med seeks clearance for low-dose orthopedic ... examining spine and joint alignment. Thus, biospace med (Paris, France/Marietta, Georgia ... the Nobel Prize in Physics in 1992, biospace med said. This detector, which is designed ...
|
|